Saccharomyces boulardii to prevent antibiotic-associated diarrhea: A randomized, double-masked, placebo-controlled trial

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Ehrhardt, Stephan ^a,b   Guo, Nan ^a   Hinz, Rebecca ^c   Schoppen, Stefanie ^b   May, Jürgen ^d   Reiser, Markus ^e   Schroeder, Maximilian Philipp ^f   Schmiedel, Stefan ^g   Keuchel, Martin ^h   Reisinger, Emil C ⁱ   Langeheinecke, Andreas ^j   de Weerth, Andreas ^k   Schuchmann, Marcus ^l,m   Schaberg, Tom ⁿ   Ligges, Sandra ^o   Eveslage, Maria ^o   Hagen, Ralf M ^c   Burchard, Gerd D ^b,g   Lohse, Ansgar W ^g   Ruf, Bernhard ^p   Porschen, Rainer ^q   Trenn, Guido ^r   Butterfaß Bahloul, Trude ^o   Wuerthwein, Gudrun ^o   Urban, Marc ^o   Oeder, Frank ^k   Runge, Andreas ^k   Klauss, Esther ^k   Hansen Rosenblatt, Nina ^k   Werner, Tobias ^g   Schulze, Kornelius ^g   Kreuels, Benno ^g   Schäfer, Guido ^g   Hübener, Peter ^g   Hennigs, Annette ^g   Beisel, Claudia ^g   Fischer Brügge, Dorothee ^g   Zimmermann Fraedrich, Katharina ^g   Röder, Claudia ^g   Grigo, Nadine ^g   Riecke, Armin ^f   Schreckenbauer, Helmut ^f   Hemmer, Christoph ⁱ   Klammt, Sebastian ⁱ   Geerdes Fenge, Hilte ⁱ   Frimmel, Silvius ⁱ   Kittner, Jens M ^l   Rey, Johannes W ^l   Schattenberg, Joern M ^l   Thieringer, Florian ^l   Schmits, Rudolf ^j   Grandt, Daniel ^j   Büch, Philipp Martin ^j   Lehnen, Sybille ^j   Tiefengraber, Daniel ^j   Radecke, Klaus ^j   Klebert, Alexander ^j   Mittag, Marc Andreas ^j   Hering, Iris ⁿ   Zeller, Wolfgang ^h   Rundt, Lisa ^h   Baltes, Peter ^h   Dajani, Dani ^h   Kurniawan, Niehls ^h   Brandt, Lars ^h   Pflüger, Carola ^h   Behjat, Nassim ^b   Engel, Ulrike ^b   Unger, Martina ^b   more..

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c Bundeswehrkrankenhaus Hamburg   (Germany)

^d Bernhard Nocht Institute for Tropical Medicine   (Germany)

^e Klinikum Vest GmbH   (Germany)

^f BUNDESWEHRKRANKENHAUS ULM   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h Bethesda Krankenhaus Bergedorf   (Germany)

ⁱ ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^j Hospital of Saarbrücken   (Germany)

^k University Medical Centre ^*  (Germany)

^l JOHANNES GUTENBERG UNIVERSITY   (Germany)

^m Cardiology and Internal Intensive Medicine   (Germany)

ⁿ Diakoniekrankenhaus Rotenburg Wümme GmbH   (Germany)

^o UNIVERSITY OF MÜNSTER   (Germany)

^p Klinikum St Georg   (Germany)

^q KLINIKUM BREMEN OST   (Germany)

^r Knappschaftskrankenhaus Bottrop   (Germany)

more..

Author keywords

Antibiotic associated diarrhea; Clostridium difficile associated diarrhea; Probiotic; Randomized controlled trial; Saccharomyces boulardii

Indexed keywords

C REACTIVE PROTEIN; PERENTEROL; PLACEBO;

ABDOMINAL CRAMP; ADULT; ANTIBIOTIC ASSOCIATED DIARRHEA; ARTICLE; CHOLECYSTITIS; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DECREASED APPETITE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FECES ANALYSIS; FEMALE; FLATULENCE; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; INTESTINE FUNCTION; KIDNEY FAILURE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA AND VOMITING; PHASE 3 CLINICAL TRIAL; PLEURA EMPYEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES BOULARDII; SEPSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 85000580131     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw011     Document Type: Article

References (25)

1. Bartlett JG, Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346:334-9.
2. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998; 16:292-307.
3. Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012; 157:878-88.
4. Bergogne-Berezin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 2000; 16:521-6.
5. Kyne L, Hamel MB, Polavaram R, Kelly CP, et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
6. McFarland LV. From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis 2015; 60:S85-90.
7. Elmer GW. Probiotics: "living drugs".AmJHealthSystPharm 2001;58: 1101-9.
8. Antunes LC, Han J, Ferreira RB, et al. Effect of antibiotic treatment on the intes- tinal metabolome. Antimicrob Agents Chemother 2011; 55:1494-503.
9. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandom- ized trials. Am J Clin Nutr 2010; 91:687-703.
10. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005; 22:365-72.
11. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associ- ated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22.
12. Lynen Jansen P, Stallmach A, Lohse AW, Lerch MM, et al. [Development of gastrointestinal infectious diseases between 2000 and 2012]. Z Gastroenterol 2014; 52:549-57.
13. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372:825-34.
14. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med 2005; 257:78-92.
15. Müller HH, Schäfer H. A general statistical principle for changing a design any time during the course of a trial. Stat Med 2004; 23:2497-508.
16. Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika 1981; 68:373-9.
17. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, random- ized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107:922-31.
18. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus prepara- tion to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335:80.
19. Gao XW, Mubasher M, Fang CY, et al. Dose-response efficacy of a proprietary pro- biotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636-41.
20. Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the preven- tion of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multi- centre trial. Lancet 2013; 382:1249-57.
21. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treat- ment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307:1959-69.
22. Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6:374-82.
23. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastro- enterol 2011; 45:S149-53.
24. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostrid- ium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5:CD006095.
25. Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012; 35:1355-69.